Skip to main content
. 2011 Dec 8;10:111. doi: 10.1186/1475-2840-10-111

Table 2.

Myocardial Metabolic and Function Variables

Variable HIV-/MC- (n = 22) HIV-/MC+ (n = 9) HIV+/MC- (n = 15) HIV+/MC+ (n = 23)
MVO2 (μmol/g/min) 4.3 ± 1.0 4.5 ± 1.3 3.9 ± 1.1 4.3 ± 1.1
MBF (ml/g/min) 0.97 ± 0.19 1.06 ± 0.22 0.92 ± 0.26 0.97 ± 0.29
GLUT (nmol/g/min) 242 ± 141 139 ± 71 184 ± 135 113 ± 66
Glycolysis (nmol/g/min) 69 ± 54 40 ± 30 80 ± 89 81 ± 39
Glycogen formation (nmol/g/min) 147 ± 82 127 ± 57 118 ± 90 35 ± 34
Lactate production (nmol/g/min) 10 ± 11 5 ± 7 18 ± 35 6 ± 9
Glucose oxidation (nmol/g/min) 62 ± 43 34 ± 23 70 ± 67 33 ± 33
EF Total (%) 42 ± 8 38 ± 6* 49 ± 19 37 ± 8
FAOX (nmol/g/min) 133 ± 56 145 ± 44 115 ± 47 97 ± 38
FAOX/MVO2 30 ± 13 34 ± 11 32 ± 15 23 ± 9
FAEST (nmol/g/min) 19 ± 20 10 ± 11 35 ± 28 24 ± 23
FAUT (nmol/g/min) 110 ± 89 155 ± 43 149 ± 55 122 ± 40
HR (bpm) 57 ± 7 72 ± 10 60 ± 14 62 ± 10
SBP (mm/Hg) 116 ± 12 134 ± 1 125 ± 20 127 ± 14
DBP (mm/Hg) 63 ± 10 73 ± 9 73 ± 11 74 ± 9
RPP (arbitrary units) 6269 ± 1737 9684 ± 1864 7488 ± 1775 7896 ± 1666
LVM MM (g) 185 ± 29 230 ± 42§ 185 ± 40 189 ± 41
EDV (mL) 125 ± 23 129 ± 18 101 ± 25 110 ± 24
ESV (mL) 52 ± 12 53 ± 13 39 ± 10 44 ± 13
EF (%) 58 ± 4 59 ± 6 61 ± 5 60 ± 8
LVET (ms) 319 ± 25 272 ± 17 313 ± 37 297 ± 29
Sm (cm/s) 8 ± 1 8 ± 2 8 ± 1 8 ± 1
E wave (cm/s) 74 ± 15 59 ± 21 71 ± 14 66 ± 16
E/A ratio 2.1 ± 0.6 1.5 ± 0.5 1.7 ± 0.6 1.4 ± 0.5
Em (cm/s) 17.2 ± 1.9 12.1 ± 2.4§ 13.9 ± 1.7 12.8 ± 2.0
DT (ms) 178 ± 29 197 ± 21 198 ± 35 202 ± 48
IVRT (ms) 80 ± 13 74 ± 8 79 ± 8 80 ± 7

Data expressed as mean ± SD. MVO2: myocardial oxygen consumption, MBF: myocardial blood flow, GLUT: myocardial glucose utilization, EFTotal: myocardial fatty acid extraction fraction total, FAOX: fatty acid oxidation, FAEST: fatty acid esterification, FAUT: fatty acid utilization, LVM = left ventricular mass, LVMI: left ventricular mass index, EDV: end diastolic volume, ESV: end systolic volume, EF: ejection fraction, LVET: left ventricular ejection time, Em: average myocardial relaxation velocity during early diastole measured at the lateral wall and septal bases, DT: deceleration time, and IVRT: isovolumic contraction time. *: p < 0.05 vs. HIV-/MC- and HIV-/MC+, : p < 0.05 vs. HIV-/MC-, : p < 0.05 vs. remaining groups, §: p < 0.05 vs. HIV-/MC- and HIV+/MC-, ¶: p < 0.05 vs. HIV+/MC-.